20
Participants
Start Date
September 30, 2003
Primary Completion Date
January 31, 2011
Study Completion Date
January 31, 2011
rosiglitazone
Rosiglitazone 4mg, one capsule per day for eight weeks
placebo
matched placebo for rosiglitazone 4mg/day
Massachusetts General Hospital Schizophrenia Program, Boston
National Alliance for Research on Schizophrenia and Depression
OTHER
Stanley Medical Research Institute
OTHER
Massachusetts General Hospital
OTHER